Leonardo Velazco-Cruz

Leonardo Velazco-Cruz

Auto-generated profile, based on publicly available information

Leonardo Velazco-Cruz

Division of Endocrinology, Metabolism and Lipid Research, Washington University School of Medicine, St. Louis, MO 63110, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2020 in Cell Reports
Verified
Journal Article
Open access
PAPunn Augsornworawat
Punn Augsornworawat
KMKristina G. Maxwell
Kristina G. Maxwell
LVLeonardo Velazco-Cruz
Leonardo Velazco-Cruz
JMJeffrey R. Millman
Jeffrey R. Millman
Human pluripotent stem cells differentiated to insulin-secreting β Cells (SC-β Cells) in islet organoids could provide an unlimited cell source for diabetes cell replacement therapy. However, current SC-β Cells generated in vitro are transcriptionally and functionally immature compared to native adult β Cells. Here, we use single-cell transcriptomic profiling to catalog changes that occur in transplanted SC-β Cells. We find that transplanted SC-β Cells exhibit drastic transcriptional changes and mature to more closely resemble adult β Cells. Insulin and IAPP protein secretions increase upon transplantation, along with expression of maturation genes lacking with differentiation in vitro, including INS, MAFA, CHGB, and G6PC2. Other differentiated cell types, such as SC-α and SC-enterochromaffin (SC-EC) cells, also exhibit large transcriptional changes. This study provides a comprehensive resource for understanding human islet cell maturation and provides important insights into maturation of SC-β Cells and other SC-islet cell types to enable future differentiation strategy improvements.

22 April 2020 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
KMKristina G. Maxwell
Kristina G. Maxwell
PAPunn Augsornworawat
Punn Augsornworawat
LVLeonardo Velazco-Cruz
Leonardo Velazco-Cruz
MKMichelle H. Kim
Michelle H. Kim
RARie Asada
Rie Asada
JMJeffrey R. Millman
Jeffrey R. Millman
Patient stem cell–derived β cells corrected for a diabetes-causing variant in WFS1 restore glucose homeostasis when transplanted into diabetic mice.